Cardinal Strategic Wealth Guidance Lowers Stock Holdings in Colgate-Palmolive (NYSE:CL)

Cardinal Strategic Wealth Guidance lowered its stake in Colgate-Palmolive (NYSE:CL) by 8.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,333 shares of the company’s stock after selling 475 shares during the period. Cardinal Strategic Wealth Guidance’s holdings in Colgate-Palmolive were worth $485,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $36,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter worth $42,000. Synergy Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $49,000. Finally, Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive in the 3rd quarter worth about $53,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $85.94 on Tuesday. The stock has a 50 day moving average price of $90.36 and a 200-day moving average price of $96.77. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The stock has a market cap of $70.21 billion, a price-to-earnings ratio of 24.41, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.